Centene (NYSE:CNC) Shares Gap Down – Here’s Why

Centene Corporation (NYSE:CNC) shares gapped down prior to trading on Tuesday . The stock had previously closed at $64.08, but opened at $59.51. Centene shares last traded at $58.2790, with a volume of 2,347,382 shares changing hands.

Key Centene News

Here are the key news stories impacting Centene this week:

• Positive Sentiment: Second-quarter results beat expectations. Centene reported adjusted diluted EPS of $2.51, compared with analyst estimates ranging from $0.89 to $1.08, versus a $0.16 loss a year earlier. Revenue rose 9.9% year over year to approximately $53.6 billion, also exceeding consensus. Centene Q2 earnings and revenues surpass estimates
• Positive Sentiment: Profitability and cost control improved significantly. The health benefits ratio declined to 89.6% from 93.0% a year earlier, while the commercial segment’s ratio improved to 79.2%. Management attributed the stronger performance to better cost management and favorable results in Medicare Advantage and prescription-drug plans. Centene raises annual profit forecast on better cost control
• Positive Sentiment: Centene raised its 2026 outlook. The company now expects adjusted diluted EPS above $4.80, versus the prior market consensus of about $3.49, and revenue of $193.5 billion to $197.5 billion, above the roughly $190.5 billion consensus. GAAP diluted EPS guidance was raised to above $3.11. Centene reports second-quarter 2026 results
• Neutral Sentiment: Board changes were announced. Director Kenneth A. Burdick retired from Centene’s board, effective July 28. The company did not indicate that the change would affect its operating outlook. Centene announces board changes
• Negative Sentiment: Investors may be taking profits or demanding evidence of sustained improvement. Despite the earnings beat and raised forecast, Centene still reported a negative net margin, while healthcare-cost trends and membership performance remain important risks for future quarters. The stock’s decline suggests the market may have already priced in much of the recovery.

Analyst Upgrades and Downgrades

CNC has been the subject of a number of research analyst reports. Wells Fargo & Company set a $69.00 price target on Centene and gave the company an “equal weight” rating in a report on Monday, July 13th. Wall Street Zen upgraded shares of Centene from a “buy” rating to a “strong-buy” rating in a research report on Saturday, July 18th. Zacks Research downgraded shares of Centene from a “strong-buy” rating to a “hold” rating in a research report on Monday, June 29th. The Goldman Sachs Group reissued a “sell” rating and issued a $40.00 price target on shares of Centene in a research report on Wednesday, April 29th. Finally, Royal Bank Of Canada upped their price objective on shares of Centene from $70.00 to $71.00 and gave the company a “sector perform” rating in a research note on Thursday, July 9th. Seven investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $64.61.

Centene Trading Down 1.3%

The business’s 50-day moving average price is $63.57 and its 200-day moving average price is $49.85. The firm has a market capitalization of $31.23 billion, a PE ratio of -4.81, a price-to-earnings-growth ratio of 0.50 and a beta of 1.07. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.12 and a quick ratio of 1.12.

Centene (NYSE:CNC) last released its quarterly earnings results on Monday, July 27th. The company reported $2.51 EPS for the quarter, beating the consensus estimate of $1.08 by $1.43. The firm had revenue of $53.58 billion during the quarter, compared to the consensus estimate of $47.64 billion. Centene had a negative net margin of 3.25% and a positive return on equity of 5.57%. Centene’s revenue for the quarter was up 9.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.16) EPS. As a group, analysts expect that Centene Corporation will post 3.44 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Centene

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Trust Asset Management LLC purchased a new stake in Centene during the 2nd quarter valued at approximately $346,000. Tema ETFs LLC increased its holdings in shares of Centene by 10.4% in the second quarter. Tema ETFs LLC now owns 9,261 shares of the company’s stock valued at $594,000 after purchasing an additional 870 shares during the period. Fulton Bank N.A. purchased a new stake in shares of Centene during the second quarter worth approximately $296,000. Wealthcare Advisory Partners LLC acquired a new stake in shares of Centene during the second quarter worth $250,000. Finally, World Equity Group Inc. acquired a new position in Centene in the 2nd quarter valued at $535,000. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.